Annual revenue:
$2.79B+$400.35M(+16.73%)Summary
- As of today (June 21, 2025), AMRX annual revenue is $2.79 billion, with the most recent change of +$400.35 million (+16.73%) on December 31, 2024.
- During the last 3 years, AMRX annual revenue has risen by +$700.29 million (+33.45%).
- AMRX annual revenue is now at all-time high.
Performance
AMRX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$695.42M-$35.10M(-4.80%)Summary
- As of today (June 21, 2025), AMRX quarterly revenue is $695.42 million, with the most recent change of -$35.10 million (-4.80%) on March 31, 2025.
- Over the past year, AMRX quarterly revenue has increased by +$36.23 million (+5.50%).
- AMRX quarterly revenue is now -4.80% below its all-time high of $730.52 million, reached on December 31, 2024.
Performance
AMRX Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$2.83B+$36.23M(+1.30%)Summary
- As of today (June 21, 2025), AMRX TTM revenue is $2.83 billion, with the most recent change of +$36.23 million (+1.30%) on March 31, 2025.
- Over the past year, AMRX TTM revenue has increased by +$334.93 million (+13.42%).
- AMRX TTM revenue is now at all-time high.
Performance
AMRX TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
AMRX Revenue Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +16.7% | +5.5% | +13.4% |
3 y3 years | +33.5% | +39.8% | +34.9% |
5 y5 years | +71.8% | +39.5% | +68.6% |
AMRX Revenue Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +33.5% | -4.8% | +39.8% | at high | +34.9% |
5 y | 5-year | at high | +71.8% | -4.8% | +49.7% | at high | +68.6% |
alltime | all time | at high | +174.4% | -4.8% | +173.0% | at high | +989.1% |
AMRX Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $695.42M(-4.8%) | $2.83B(+1.3%) |
Dec 2024 | $2.79B(+16.7%) | $730.52M(+4.0%) | $2.79B(+4.2%) |
Sep 2024 | - | $702.47M(+0.1%) | $2.68B(+3.2%) |
Jun 2024 | - | $701.78M(+6.5%) | $2.60B(+4.1%) |
Mar 2024 | - | $659.19M(+6.8%) | $2.50B(+4.2%) |
Dec 2023 | $2.39B(+8.2%) | $616.98M(-0.5%) | $2.39B(+0.3%) |
Sep 2023 | - | $620.04M(+3.5%) | $2.39B(+3.2%) |
Jun 2023 | - | $599.05M(+7.4%) | $2.31B(+1.7%) |
Mar 2023 | - | $557.54M(-8.6%) | $2.27B(+2.7%) |
Dec 2022 | $2.21B(+5.7%) | $609.76M(+11.8%) | $2.21B(+3.4%) |
Sep 2022 | - | $545.56M(-2.5%) | $2.14B(+0.8%) |
Jun 2022 | - | $559.36M(+12.4%) | $2.12B(+1.2%) |
Mar 2022 | - | $497.63M(-7.3%) | $2.10B(+0.2%) |
Dec 2021 | $2.09B | $536.90M(+1.6%) | $2.09B(+1.3%) |
Sep 2021 | - | $528.59M(-1.2%) | $2.07B(+0.5%) |
Jun 2021 | - | $535.08M(+8.5%) | $2.06B(+3.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2021 | - | $493.11M(-3.3%) | $1.99B(-0.3%) |
Dec 2020 | $1.99B(+22.5%) | $510.03M(-1.8%) | $1.99B(+6.0%) |
Sep 2020 | - | $519.29M(+11.8%) | $1.88B(+8.1%) |
Jun 2020 | - | $464.66M(-6.8%) | $1.74B(+3.6%) |
Mar 2020 | - | $498.53M(+25.5%) | $1.68B(+3.2%) |
Dec 2019 | $1.63B(-2.2%) | $397.33M(+5.0%) | $1.63B(-5.8%) |
Sep 2019 | - | $378.28M(-6.5%) | $1.73B(-5.4%) |
Jun 2019 | - | $404.64M(-9.3%) | $1.82B(-0.5%) |
Mar 2019 | - | $446.12M(-10.3%) | $1.83B(+10.3%) |
Dec 2018 | $1.66B(+60.9%) | $497.53M(+4.4%) | $1.66B(+14.0%) |
Sep 2018 | - | $476.49M(+15.2%) | $1.46B(+17.9%) |
Jun 2018 | - | $413.79M(+50.4%) | $1.24B(+14.2%) |
Mar 2018 | - | $275.19M(-6.2%) | $1.08B(+34.1%) |
Dec 2017 | $1.03B(+1.5%) | $293.37M(+15.2%) | $807.97M(+57.0%) |
Sep 2017 | - | $254.73M(-2.0%) | $514.60M(+98.0%) |
Jun 2017 | - | $259.87M | $259.87M |
Dec 2016 | $1.02B | - | - |
FAQ
- What is Amneal Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals annual revenue year-on-year change?
- What is Amneal Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals quarterly revenue year-on-year change?
- What is Amneal Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals TTM revenue year-on-year change?
What is Amneal Pharmaceuticals annual revenue?
The current annual revenue of AMRX is $2.79B
What is the all time high annual revenue for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high annual revenue is $2.79B
What is Amneal Pharmaceuticals annual revenue year-on-year change?
Over the past year, AMRX annual revenue has changed by +$400.35M (+16.73%)
What is Amneal Pharmaceuticals quarterly revenue?
The current quarterly revenue of AMRX is $695.42M
What is the all time high quarterly revenue for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high quarterly revenue is $730.52M
What is Amneal Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, AMRX quarterly revenue has changed by +$36.23M (+5.50%)
What is Amneal Pharmaceuticals TTM revenue?
The current TTM revenue of AMRX is $2.83B
What is the all time high TTM revenue for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high TTM revenue is $2.83B
What is Amneal Pharmaceuticals TTM revenue year-on-year change?
Over the past year, AMRX TTM revenue has changed by +$334.93M (+13.42%)